Tuesday, August 20, 2019
Home Authors Posts by Editor / Curator

Editor / Curator

119 POSTS 0 COMMENTS
Biotech News

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase...

Editor / Curator -
eCommerce

MySize (MYSZ) in Jerusalem Post.

Editor / Curator -
Fintech

Short Squeeze Alert.

Editor / Curator -
Internet News

My Size (MYSZ) Provides Business Update and Reports Results for the...

Editor / Curator -
mysize, internet stock review
eCommerce

World’s Largest Performance Apparel Co., Gearing up for MySize (MYSZ) Smart...

Editor / Curator -
Biotech News

Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo...

Editor / Curator -
Biotech News

Biotech Stock Review Adds Hancock Jaffe (HJLI) $1.05 to Watch List.

Editor / Curator -
Institutional Analyst Newsletter

Guess Who This Beautiful Chart Belongs to?

Editor / Curator -
Biotech News

Innovus (INNV) New E-Commerce Store on Track for $3 million in...

Editor / Curator -
Internet News

My Size (MYSZ) Signs License Agreement With Penti for Smart Body...

Editor / Curator -
123...12Page 1 of 12

Latest article

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase from Prior Quarter.

Biotech News Editor / Curator -
Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter...

MySize (MYSZ) in Jerusalem Post.

eCommerce Editor / Curator -
Israeli Start-Up MySize Eases Retail's Online Returns Problems. While the company launched its SizeUp application in late 2015,...

Short Squeeze Alert.

Fintech Editor / Curator -
Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.